Clinical Trials on Arthrogryposis Multiplex Congenita
Total 16106 results
-
University Hospital, GrenobleRecruitingArthrogryposis Multiplex Congenita (AMC)France
-
University Hospital, GrenobleCompletedPediatric ALL | Arthrogryposis Multiplex Congenita | AMC-Arthrogryposis Multiplex CongenitaFrance
-
University Hospital, GrenobleNot yet recruitingArthrogryposis Multiplex Congenita (AMC)
-
Freeman-Sheldon Research Group, Inc.TerminatedCraniofacial Abnormalities | Arthrogryposis | Freeman-Sheldon Syndrome | Arthrogryposis Distal Type 2A | Whistling Face Syndrome | Craniocarpotarsal Dysplasia | Craniocarpotarsal Dystrophy | Freeman-Sheldon Syndrome Variant | Sheldon-Hall Syndrome | Arthrogryposis Distal Type 2B | Gordon Syndrome | Arthrogryposis... and other conditionsUnited States
-
University Hospital, GrenobleCompletedDiagnosis of Arthrogryposis Amyoplasia or Distal Arthrogryposis | 5 Day Multidisciplinary Evaluation in AMC Clinic of the National Reference Center | With Physical Medecin, Medical Genetic and Imaging Departments at the Hospital Grenoble AlpesFrance
-
Dufresne, Craig, MD, PCRecruitingFreeman-Sheldon Syndrome | Whistling Face Syndrome | Freeman-Sheldon Syndrome Variant | Sheldon-Hall Syndrome | Gordon Syndrome | Arthrogryposis Distal Type 3 | Arthrogryposis Distal Type 1 | Freeman-Burian SyndromeUnited States
-
Nemours Children's ClinicNot yet recruiting
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedPolycystic Kidney, Autosomal DominantUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPolycystic Kidney, Autosomal DominantBelgium, Germany, Italy, Spain, Sweden, United States, Canada, Australia, Netherlands, Czechia, Poland, Denmark, Israel, Hungary, Russian Federation, South Africa, United Kingdom, Romania, Argentina, Norway
-
Freeman-Sheldon Research Group, Inc.WithdrawnCraniofacial Abnormalities | ArthrogryposisUnited States
-
Kadmon, a Sanofi CompanyCompletedPolycystic Kidney, Autosomal DominantUnited States
-
Carolina CannilloCompletedPolycystic Kidney, Autosomal DominantDenmark
-
PfizerCompletedPolycystic Kidney, Autosomal DominantUnited States, Canada, Australia, Sweden, Spain, Poland, Korea, Republic of, Switzerland, United Kingdom, Moldova, Republic of, Italy, Czech Republic, Hungary, Lithuania, Romania, Slovakia, Turkey
-
Palladio BiosciencesCentessa Pharmaceuticals plcTerminatedAutosomal Dominant Polycystic Kidney | ADPKDUnited States, Spain, Hungary, United Kingdom, Australia, Bulgaria, Poland, Turkey
-
Kadmon, a Sanofi CompanyCompletedAutosomal Dominant Polycystic Kidney | ADPKDUnited States
-
Lisbet BrandiUnknownAutosomal Dominant Polycystic KidneyDenmark
-
Kyongtae Ty Bae, M.D., Ph.D.University of Maryland, Baltimore; United States Department of Defense; University... and other collaboratorsCompletedPolycystic Kidney, Autosomal DominantUnited States
-
Esther MeijerUnknownPolycystic Kidney, Autosomal Dominant | Autosomal Dominant Polycystic Kidney | ADPKDNetherlands
-
Geisinger ClinicPatient-Centered Outcomes Research InstituteCompletedIntellectual Disability | Autism | Multiple Congenital Anomalies
-
The Rogosin InstituteWeill Medical College of Cornell University; Rockefeller UniversityCompletedChronic Kidney Disease | Polycystic Kidney, Autosomal DominantUnited States
-
Regulus Therapeutics Inc.CompletedPolycystic Kidney Disease, Autosomal DominantUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedPolycystic Kidney Disease, Autosomal DominantUnited States, Belgium, United Kingdom, Russian Federation, France, Australia, Netherlands, Italy, Japan, Denmark, Romania, Poland, Canada, Argentina, Germany
-
University of ZurichCompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)Switzerland
-
Istanbul UniversityCompletedAutosomal Dominant Polycystic Kidney DiseaseTurkey
-
University of Colorado, DenverPKD FoundationCompletedPolycystic Kidney, Autosomal DominantUnited States
-
Changlin MeiThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsCompletedPolycystic Kidney, Type 1 Autosomal Dominant DiseaseChina
-
UConn HealthRecruitingAplasia Cutis CongenitaUnited States
-
Baylor College of MedicineCompletedNeurodevelopmental Disorders | Birth Defects | Multiple Congenital AnomalyUnited States
-
Galapagos NVTerminatedAutosomal Dominant Polycystic Kidney DiseaseBelgium, Netherlands, Italy, Spain, Czechia, Germany, Poland
-
Palladio BiosciencesCompletedAutosomal Dominant Polycystic Kidney DiseaseUnited States
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPolycystic Kidney, Autosomal DominantUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States, Australia, Belgium, Germany, Italy, Poland, Romania, United Kingdom, Argentina, Canada, France, Netherlands, Russian Federation
-
Otsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney Disease （ADPKD)Japan
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney DiseaseUnited States
-
Otsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney DiseaseJapan
-
Shanghai Changzheng HospitalUnknownAutosomal Dominant Polycystic Kidney Disease (ADPKD)China
-
Yale UniversityTerminatedAutosomal Dominant Polycystic Kidney DiseaseUnited States
-
University of Colorado, DenverUniversity of MarylandRecruitingPolycystic Kidney, Autosomal DominantUnited States
-
Regional Hospital HolstebroCompletedChronic Kidney Diseases | Polycystic Kidney, Autosomal DominantDenmark
-
University of ChicagoWithdrawn
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPolycystic Kidney, Autosomal DominantUnited States
-
Mayo ClinicCompletedKidney Disease | Autosomal Dominant Polycystic Kidney DiseaseUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, France, Germany, Italy, Japan, Netherlands, Norway, Poland, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Mario Negri Institute for Pharmacological ResearchTerminatedSirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency (SIRENA-II)Autosomal Dominant Polycystic Kidney Disease (ADPKD)Italy
-
Korea Otsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)Korea, Republic of
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney DiseaseNetherlands
-
Otsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney DiseaseJapan
-
Kyorin UniversityOtsuka Pharmaceutical Co., Ltd.CompletedAutosomal Dominant Polycystic Kidney DiseaseJapan
-
University of KansasCompletedAutosomal Dominant Polycystic Kidney DiseaseUnited States
-
University of KansasCompletedAutosomal Dominant Polycystic Kidney DiseaseUnited States